← Leaderboards
Michael Joseph Satlin
Weill Medical Coll Of Cornell Univ
$3,693,103
Attributed
$3,693,103
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $656.9K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,693,103 · 4
By mechanism
R01$2,132,309 · 1
K23$925,169 · 1
R21$466,125 · 1
R03$169,500 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Chemotherapy”
- George R Seage · Abt Associates, Inc.$223,371,661
- Charles A Coltman · Southwest Oncology Group$170,244,220
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$154,566,243
- Philip J Disaia · University Of California Irvine$115,055,799
- Norman Wolmark · Nsabp Foundation, Inc.$106,367,723
Research focus
ChemotherapyRisk FactorsNeutropeniaFluoroquinolonesScreeningHematologic NeoplasmsPrevalenceHigh RiskDesignMortalityPublic HealthSwabAnti-Bacterial AgentsResistanceGram-Negative BacteriaPathogenBacterial InfectionsNovel StrategiesAntibioticsLeadEnterobacteriaceae16s Ribosomal Rna SequencingFecesFluoroquinolone Resistance
Grant awards (13)
Screening for Fluoroquinolone-Resistant Viridans Group Streptococci to Individualize Infection Prevention Strategies in Neutropenic Patients$254,250
R21 · FY2025 · AI · contact PI
Screening for Fluoroquinolone-Resistant Viridans Group Streptococci to Individualize Infection Prevention Strategies in Neutropenic Patients$211,875
R21 · FY2024 · AI · contact PI
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients$519,904
R01 · FY2023 · AI · contact PI
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients$514,678
R01 · FY2022 · AI · contact PI
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients$525,544
R01 · FY2021 · AI · contact PI
Predicting Infections in Neutropenic Hosts Receiving Fluoroquinolone Prophylaxis$84,750
R03 · FY2021 · AI · contact PI
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients$572,183
R01 · FY2020 · AI · contact PI
Predicting Infections in Neutropenic Hosts Receiving Fluoroquinolone Prophylaxis$84,750
R03 · FY2020 · AI · contact PI
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia$191,015
K23 · FY2019 · AI · contact PI
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia$191,015
K23 · FY2018 · AI · contact PI
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia$191,015
K23 · FY2017 · AI · contact PI
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia$176,062
K23 · FY2016 · AI · contact PI
Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia$176,062
K23 · FY2015 · AI · contact PI